Topics

Companies Related to "Evaluating the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Uncontrolled Asthma" [Most Relevant Company Matches] RSS

04:48 EST 25th February 2020 | BioPortfolio

Here are the most relevant search results for "Evaluating the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Uncontrolled Asthma" found in our extensive corporate database of over 50,000 company records.

Showing "Evaluating Safety Tolerability Clinical Activity EQ001 Uncontrolled Asthma" Companies 1–25 of 7,000+

Relevant

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...


Asthmatx Inc.

Asthma is one of the most common and costly diseases in the world. The prevalence of asthma has grown in recent decades, and there is no cure. According to the Asthma and Allergy Foundation of America (AAFA), more than 20 million Americans have asthma, and managing asthma consumes over $18 billion of healthcare resources each year. In the U.S. each year, asthma attacks result in approximately 10 m...

Asthmatx, Inc.

Asthma is one of the most common and costly diseases in the world. The prevalence of asthma has grown in recent decades, and there is no cure. According to the Asthma and Allergy Foundation of America (AAFA), more than 20 million Americans have asthma, and managing asthma consumes over $18 billion of healthcare resources each year. In the U.S. each year, asthma attacks result in approximately 10 m...


Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed an industr...

Allergy & Asthma Associates of Northern California

Asthma patients may be treated by primary care physicians, by asthma specialists, or by a combination of health care providers. Until recently, the question of who achieves the best outcomes at less cost has been poorly answered with miscellaneous data, anecdotal evidence, untested assumptions and educated guesses. A growing number of published clinical data states that the involvement of speciali...

Wellquest

Wellquest is a 27-bedded state-of-the-art clinical research facility spread over 10,000 squarefeet on the two floors of the mordern Wellspring hospital.Wellquest has been created to conform to international standards of GCP and GLP as laid down by the ICH guidelines and the code of fedral regulations of US-FDA.Wellquest offers quality services to conduct clinical and preclinical research for the d...

Outcome Sciences, Inc.

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed more than ...

Asthmacure.com

Asthmacure.com is a free webresource on asthma disease. Asthmacure.com is an offering by Indian Asthma Care Society for providing useful information and tips for asthma patients, their family members and friends. Indian Asthma Care Society is a leading non-profit organization of India that strives to spread knowledge in the society by educating people on asthma and smoking. We achieve our goals on...

Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.son...

Aerocrine Inc

Aerocrine is a clinically based medical, technical company with headquarters in Stockholm, Sweden. It was founded in 1997 by scientists at the Karolinska Institute that first identified Nitric Oxide (NO) as a marker of inflammation. Aerocrine’s initial commitment is to develop NO analysis for asthma. The company holds a comprehensive patent portfolio in prioritized markets such as the European U...

Opsona Therapeutics Limited

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis. The company was founded in 2004 ...

Atlanta Allergy and Asthma Clinic

Atlanta Allergy and Asthma Clinic is the premier facility in the Southeast for the treatment of allergy, asthma, and immunologic diseases. We know that living with the symptoms of allergy and asthma can range from being annoying to potentially life threatening. That is why our entire focus is on you our patient. From research, to prevention, to the latest in treatment options, our goal is helping ...

ChanTest Inc.

To provideNon-Clinical drug safety testing and discovery services that accelerate drug development by:Leveraging our extensive experience in evaluating drug-induced effects on ion channels, purkinje fibers, and iolated hearts; Providing accurate, repeatable results; Consistently responding with a high sense of urgency

TheraCoat

TheraCoat is a specialty pharmaceutical company founded in 2004 by uro-oncologists and biomaterial specialists. TheraCoat’s Board of Directors and Scientific Advisory Board feature renowned scientific experts in the fields of urology, pharma top executives and experienced business veterans; among them Prof. Belldegrun and Mr. Hurvitz, both TEVA Board ...

Sonus Pharmaceuticals

SONUS PHARMACEUTICALS is focused on the development of drugs that provide better therapeutic alternatives for cancer patients,including improved efficacy,safety and tolerability,and are more convenient to use

iSonea Ltd.

iSonea Limited (formerly KarmelSonix) is an emerging medical technology company developing innovative, non-invasive Acoustic Respiratory Monitoring™ (ARM) devices and software for the management of asthma and related pulmonary disorders. ARM is a breakthrough in asthma management. ARM devices are more patient-friendly than traditional tests, addressing ...

iSonea Limited

iSonea Limited (formerly KarmelSonix) is an emerging medical technology company developing innovative, non-invasive Acoustic Respiratory Monitoring™ (ARM) devices and software for the management of asthma and related pulmonary disorders. ARM is a breakthrough in asthma management. ARM devices are more patient-friendly than traditional tests, addressing ...

Infinity Pharmaceuticals Inc.

Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, a first-in-class, oral immuno-oncology development candidate that selectively inhibits PI3K-gamma, in multiple clinical studies. MARIO-275 is a global, randomized, controlled combination study of IPI-549 combined with Opdivo in I/O naïve urothelial c...

Heal Asthma

Herbal Medicine for Asthma Cure

Opsona Therapeutics Ltd

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis. The company was founded in 2004 ...

VAPA Virginia Adult and Pediatric Allergy and Asthma

VAPA has an entire office and staff that specializes in research and is dedicated to finding newer, safer and more effective treatments for allergy and asthma patients. Our research center has been working with major pharmaceutical companies conducting clinical research since 1996. Our services are free and available to all qualified participants.

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is ag...

Advanced Biomedical Research Incorporated

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in Pennington, New Jersey adjacent to the Princeton biopharmaceutical research corridor. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and...

Allergy and Asthma Associates

Allergy and Asthma Associates is one of the oldest allergy-asthma practices in the Pacific Northwest starting in 1938 by James Stroh, Sr. Drs. James Stroh, Jr and Rick Lane Johnson joined Dr. Stroh in a Seattle office in the early 1970s. The initial contingent has recently retired; now the practice includes Drs. Gary Ayars, Charles Jackson, and D. Robert Webb, who practice in two primary locations...


More From BioPortfolio on "Evaluating the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Uncontrolled Asthma"

Quick Search

Corporate Database Quicklinks